These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 26349711

  • 1. [Nosebleed in new oral anticoagulant treatment - what should be done?].
    Stiefelhagen P.
    MMW Fortschr Med; 2015 Sep 10; 157(15):25. PubMed ID: 26349711
    [No Abstract] [Full Text] [Related]

  • 2. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A, Lin T, Plesman J, Heeger CH, Lemes C, Metzner A, Mathew S, Wissner E, Wohlmuth P, Ouyang F, Kuck KH, Tilz RR.
    J Cardiovasc Electrophysiol; 2016 Feb 10; 27(2):147-53. PubMed ID: 26464027
    [Abstract] [Full Text] [Related]

  • 3. Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
    Pham PN, Brown JD.
    BMC Cardiovasc Disord; 2019 Mar 19; 19(1):64. PubMed ID: 30890131
    [Abstract] [Full Text] [Related]

  • 4. Direct oral anticoagulant drugs (DOAC).
    Blum RA, Lindfield D.
    J Cataract Refract Surg; 2016 Jan 19; 42(1):171-2. PubMed ID: 26948793
    [No Abstract] [Full Text] [Related]

  • 5. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L, Mondoly P, Duparc A, Bura-Rivière A, Maury P, Calmels V, Sallerin B, Pathak A, Montastruc JL, Bagheri H.
    Therapie; 2015 Jan 19; 70(6):485-92. PubMed ID: 26223162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
    Ritzenthaler T, Derex L, Davenas C, Bnouhanna W, Farghali A, Mechtouff L, Cho TH, Nighoghossian N.
    Rev Neurol (Paris); 2015 Sep 19; 171(8-9):613-5. PubMed ID: 25857461
    [Abstract] [Full Text] [Related]

  • 9. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB, Swanson MT.
    Oral Maxillofac Surg Clin North Am; 2016 Nov 19; 28(4):515-521. PubMed ID: 27624772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.
    Sivolella S, De Biagi M, Brunello G, Berengo M, Pengo V.
    Odontology; 2015 Sep 19; 103(3):258-63. PubMed ID: 25656043
    [Abstract] [Full Text] [Related]

  • 12. Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.
    Beyer-Westendorf J, Ehlken B, Evers T.
    Europace; 2016 Aug 19; 18(8):1150-7. PubMed ID: 26830891
    [Abstract] [Full Text] [Related]

  • 13. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H, El-Makaty H, Ali Z.
    J Cardiovasc Pharmacol Ther; 2018 Mar 19; 23(2):155-161. PubMed ID: 28978236
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data.
    Terayama Y.
    J Stroke Cerebrovasc Dis; 2017 Jun 19; 26(6):1171-1181. PubMed ID: 28169097
    [Abstract] [Full Text] [Related]

  • 15. Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.
    Sennesael AL, Dogné JM, Spinewine A.
    JAMA Intern Med; 2015 Oct 19; 175(10):1608-9. PubMed ID: 26237648
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens.
    Providência R, Grove EL, Husted S, Barra S, Boveda S, Morais J.
    Thromb Res; 2014 Dec 19; 134(6):1253-64. PubMed ID: 25457584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.